Thank you for your interest in our webinar hosted on April 14, 2020. Though you missed our live presentation, we are delighted to provide you with the recording of this informative session you can view on demand at your leisure.
Access the recording –Sea change in HCP practices: What the pharma sales force needs to know about how COVID-19 is impacting HCP practices
COVID-19 will permanently alter HCP practices and the physician engagement model. The shift away from in-person detailing raises significant engagement questions. Practice dynamics have fundamentally changed as physician availability has been crushed by COVID-19 and HCPs move to embrace telemedicine. Telemedicine is changing office practice and logistics requirements for physicians and staff.
Delivering early insights on the sea change in HCP practices, in light of COVID-19 and the new era of HCP engagement, Ipsos is sharing the results of interim research we are conducting among HCPs, together with M360.
Watch our on-demand webinar and learn as Ipsos’ experts review the first-wave results of our new regular COVID-19 HCP Surveillance Research of 300+ HCPs across seven specialties.
We explore how COVID-19 is changing HCPs’ practice dynamics and their interactions with pharmaceutical manufacturers:
- Changes in patient volume and composition
- Changes in practice behavior, including the rise of telemedicine
- Changes in use of new communications channels with manufacturers (including the extent of e-detailing)
Further, drawing on the surveillance results, we explore considerations for best practices in creating effective virtual detailing. Glean insights from Ipsos’ data and the discussion with our experts during our interactive audience Q&A, by watching our webinar recording!
To take you further along on your journey, we would be delighted discuss the details of the research and how we can we can help your brand team reflect on the impacts of COVID-19 and reframe your plans, according to the shifts highlighted in our study.